CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project focuses on understanding the molecular interactions of the inducible co-stimulator and its ligand, which play critical roles in immune responses. The goal is to provide insights that could lead to new therapies for autoimmune diseases and cancer.
T and B lymphocytes are effectors of adaptive immunity.
Their dysregulation have dramatic health consequences, and can lead to autoimmunity and blood cancers.
Recently, immune receptors involved in dictating the fate of B and T cells have expanded drastically.
Once of these critical receptor/ligand immune pair is the inducible co-stimulator (ICOS) and its ligand ICOSL, which emerged as a novel T/B-cell co-signaling pathway.
The multiple roles reported for this immune complex position ICOS/ICOSL…
UNIVERSIDAD DEL PAIS VASCO/ EUSKAL HERRIKO UNIBERTSITATEA
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
